Abou Shousha, Mohamed
Wang, Jianhua
Kontadakis, George http://orcid.org/0000-0003-4549-7682
Feuer, William
Canto, Ana P.
Hoffmann, Rodrigo
Perez, Victor L.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Eye Institute (K23EY026118, R01EY018624, P30 EY014801, K23EY026118, R01EY018624, P30 EY014801, K23EY026118, R01EY018624, P30 EY014801, K23EY026118, R01EY018624, P30 EY014801)
Research to Prevent Blindness
Novartis | Alcon | Alcon Research Institute
Article History
Received: 22 August 2018
Revised: 13 March 2019
Accepted: 4 July 2019
First Online: 1 October 2019
Compliance with ethical standards
:
: VLP is a consultant of Alcon Ltd. MAS and VLP are equity holders and sit on the Board of Directors for Resolve Ophthalmics, LLC. They are co-inventor of intellectual property licensed to Resolve Ophthalmics. PCT/US2018/013409, and US Patent No 8992023. VLP, MAS, and JW are co-inventor of Non-Provisional United States Patent Application No.: 61809518.